BELITE BIO INC - AMERICAN DEPOSITARY SHARES
50.99
04-10月-24 15:59:47
15 分の遅延
株式
+0.09
+0.18%
本日の幅
50.49 - 51.15
ISIN
N/A
ソース
NASDAQ
-
18 11 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
20 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
01 10 2022 19:03:33 提供 Nasdaq GlobeNewswire
-
23 9 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China
16 9 2022 08:00:32 提供 Nasdaq GlobeNewswire
-
Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.
22 8 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Reports First Half 2022 Operational Highlights and Financial Results
10 8 2022 21:51:10 提供 Nasdaq GlobeNewswire
-
Belite Bio to Host Conference Call on August 11, 2022 to Discuss First Half 2022 Financial Results
01 8 2022 16:10:00 提供 Nasdaq GlobeNewswire
-
19 7 2022 16:05:33 提供 Nasdaq GlobeNewswire
-
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
12 5 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
05 5 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Belite Bio Announces Closing of $36 Million Initial Public Offering
03 5 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Receives FDA Fast Track Designation For LBS-008
03 5 2022 06:50:00 提供 Nasdaq GlobeNewswire